Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases
{{output}}
Purpose of review: Treatment of Inflammatory Bowel Diseases (IBD) is challenging; thus, the need for newer therapeutic options with an oral route of administration has led to the development of novel small molecules drugs (SMDs).... ...
